agilon health (NYSE:AGL) Given New $3.50 Price Target at Royal Bank of Canada

agilon health (NYSE:AGL) had its price objective lifted by stock analysts at Royal Bank of Canada from $3.00 to $3.50 in a research report issued on Wednesday,Benzinga reports. The brokerage presently has an “outperform” rating on the stock. Royal Bank of Canada’s target price indicates a potential downside of 3.71% from the stock’s current price.

Several other equities analysts also recently commented on AGL. Stifel Nicolaus upped their price target on shares of agilon health from $2.00 to $3.00 and gave the company a “hold” rating in a research note on Wednesday. Barclays decreased their target price on shares of agilon health from $5.00 to $2.00 and set an “underweight” rating on the stock in a research report on Monday, November 11th. Macquarie assumed coverage on shares of agilon health in a research report on Monday, December 16th. They issued a “neutral” rating and a $3.00 price target for the company. Sanford C. Bernstein increased their price target on agilon health from $2.50 to $3.15 and gave the stock a “market perform” rating in a research report on Wednesday, January 15th. Finally, TD Cowen cut their target price on agilon health from $6.00 to $2.00 and set a “hold” rating for the company in a research report on Monday, November 11th. Two equities research analysts have rated the stock with a sell rating, fourteen have given a hold rating and two have assigned a buy rating to the company. According to data from MarketBeat.com, the company currently has a consensus rating of “Hold” and a consensus target price of $4.14.

agilon health Stock Performance

Shares of NYSE:AGL traded up $0.01 on Wednesday, hitting $3.64. The company had a trading volume of 6,715,121 shares, compared to its average volume of 5,338,750. The stock has a 50 day moving average price of $2.89 and a 200 day moving average price of $3.04. The company has a current ratio of 1.29, a quick ratio of 1.29 and a debt-to-equity ratio of 0.06. The stock has a market cap of $1.50 billion, a price-to-earnings ratio of -3.86 and a beta of 0.66. agilon health has a 1-year low of $1.50 and a 1-year high of $7.73.

Insider Activity at agilon health

In other agilon health news, Director Karen Mcloughlin acquired 25,000 shares of the business’s stock in a transaction dated Friday, December 13th. The stock was purchased at an average price of $2.20 per share, with a total value of $55,000.00. Following the transaction, the director now directly owns 73,166 shares in the company, valued at approximately $160,965.20. The trade was a 51.90 % increase in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this link. Also, Director John William Wulf bought 45,000 shares of the firm’s stock in a transaction on Thursday, December 5th. The shares were purchased at an average price of $2.18 per share, for a total transaction of $98,100.00. Following the purchase, the director now owns 206,133 shares in the company, valued at $449,369.94. This trade represents a 27.93 % increase in their position. The disclosure for this purchase can be found here. Insiders purchased a total of 77,500 shares of company stock valued at $169,600 in the last 90 days. Corporate insiders own 3.20% of the company’s stock.

Institutional Investors Weigh In On agilon health

Several large investors have recently added to or reduced their stakes in the stock. Capital International Investors lifted its holdings in shares of agilon health by 72.0% in the 4th quarter. Capital International Investors now owns 22,331,873 shares of the company’s stock worth $42,431,000 after buying an additional 9,346,295 shares during the period. Millennium Management LLC grew its holdings in agilon health by 187.8% during the 4th quarter. Millennium Management LLC now owns 7,212,525 shares of the company’s stock worth $13,704,000 after acquiring an additional 4,706,357 shares in the last quarter. Citigroup Inc. increased its position in agilon health by 2,251.5% during the 3rd quarter. Citigroup Inc. now owns 2,028,246 shares of the company’s stock valued at $7,971,000 after purchasing an additional 1,941,993 shares during the period. Algert Global LLC lifted its position in shares of agilon health by 1,042.7% in the 4th quarter. Algert Global LLC now owns 2,108,687 shares of the company’s stock worth $4,007,000 after purchasing an additional 1,924,157 shares during the period. Finally, Charles Schwab Investment Management Inc. boosted its stake in shares of agilon health by 49.2% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 4,541,549 shares of the company’s stock valued at $8,629,000 after purchasing an additional 1,498,524 shares in the last quarter.

About agilon health

agilon health, inc. provides healthcare services for seniors through primary care physicians in the communities of the United States. It offers a platform that manages the total healthcare needs of the patients by subscription-like per-member per-month. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc.